Skip to main content
. 2014 Jan 24;63(3):55–58.

TABLE 2.

Indicators of viral suppression among persons aged ≥13 years who had HIV infection diagnosed in 2010 and were retained in care* (N = 1,340), by selected characteristics — Georgia

Characteristic Prevalence ratio (95% CI) p value
Race/Ethnicity
 Black 0.9 (0.8–0.9) <0.01
 White (reference group) 1.0
 Hispanic 1.0 (0.9–1.2) 0.70
 Other/Unknown 1.1 (1.0–1.2) 0.07
Age group (yrs) §
 13–24 0.8 (0.7–0.9) <0.01
 25–34 0.9 (0.7–1.0) 0.17
 35–44 0.9 (0.8–1.0) 0.23
 45–54 0.9 (0.9–1.1) 0.33
 ≥55 (reference group) 1.0
Disease stage at diagnosis
 1 0.8 (0.7–0.9) <0.01
 2 0.9 (0.8–1.0) 0.02
 3 (reference group) 1.0
 Unknown 0.8 (0.8–0.9) <0.01
Sex
 Male 1.0
 Female 1.0 (0.9–1.1) 0.97

Abbreviation: CI = confidence interval.

*

Retained in care defined as having at least two laboratory tests (CD4+ or viral load) at least 3 months apart during 4–15 months after diagnosis.

Among persons residing in Georgia and having a positive Western Blot or viral load based on surveillance data reported during 2010. Viral suppression defined as viral load <200 on the basis of most recent test during 4–15 months after diagnosis. Only includes persons with their sex recorded at birth.

§

Age based on the person’s age at year’s end 2010.

Based on first recorded CD4+ cell count ≤3 months after diagnosis. Defined as stage 1: CD4+ count ≥500 cells/μL or CD4+ percentage of total lymphocytes ≥29; stage 2: CD4+ count of 200–499 cells/μL or CD4+ percentage of total lymphocytes of 14–28; and stage 3: CD4+ count of <200 cells/μL or CD4+ percentage of total lymphocytes of <14.